分享好友 资讯首页 频道列表

AB InBev Reports Full Year and Fourth Quarter 2025 Results

2026-02-13 09:4018230

Underlying EPS increased by 6% with continued margin expansion and free cash flow generation of 11.3 billion USD

BRUSSELS--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD):

Regulated and inside information1

“Beer plays an important role in bringing people together and creating moments of celebration. In 2025, we executed our strategy, made disciplined capital allocation choices and delivered growth within our outlook for the year, even as we navigated a dynamic consumer environment. We exit 2025 with improved momentum and enter 2026 well positioned to engage consumers with our megabrands and an unparalleled lineup of mega platforms. Thank you to our colleagues for their ongoing commitment, hard work and passion for our business.” – Michel Doukeris, CEO, AB InBev

Revenue

4Q +2.5% | FY +2.0%

Revenue increased by 2.5% in 4Q25 with revenue per hl growth of 4.0% and by 2.0% in FY25 with revenue per hl growth of 4.4%.

 

Reported revenue increased by 4.8% in 4Q25 to 15 555 million USD and decreased by 0.8% in FY25 to 59 320 million USD, impacted by unfavorable currency translation.

 

Volumes

4Q -1.5% | FY -2.3%

Volumes declined by 1.5% in 4Q25, with beer volumes down by 1.9% and non-beer volumes up by 0.6%.

 

Volumes declined by 2.3% in FY25, with beer volumes down by 2.6% and non-beer volumes down by 0.4%.

 

Normalized EBITDA

4Q +2.3% | FY +4.9%

Normalized EBITDA increased by 2.3% to 5 473 million USD in 4Q25, with a margin contraction of 10bps to 35.2%.

 

Normalized EBITDA increased by 4.9% to 21 223 million USD in FY25, with a margin expansion of 101 bps to 35.8%.

 

Underlying Profit

4Q 1 884 | FY 7 410 million USD

Underlying Profit was 1 884 million USD in 4Q25 compared to 1 770 million USD in 4Q24 and was 7 410 million USD in FY25 compared to 7 061 million USD in FY24.

 

Reported profit attributable to equity holders of AB InBev was 1 959 million USD in 4Q25 compared to 1 220 million USD in 4Q24 and was 6 837 million USD in FY25 compared to 5 855 million USD in FY24.

 

Underlying EPS

4Q 0.95 | FY 3.73 USD

Underlying EPS increased by 7.5% to 0.95 USD in 4Q25, compared to 0.88 USD in 4Q24, and increased by 6.0% to 3.73 USD in FY25, compared to 3.53 USD in FY24.

 

On a constant currency basis, Underlying EPS increased by 2.1% in 4Q25 and by 9.4% in FY25.

 

Net Debt to EBITDA

2.87x

Net debt to normalized EBITDA ratio was 2.87x at 31 December 2025, compared to 2.89x at 31 December 2024.

Capital Allocation

Dividend 1.00 EUR

The AB InBev Board of Directors proposes a final dividend of 1.00 EUR per share, subject to shareholder approval at the AGM on 29 April 2026. Combined with the interim dividend of 0.15 EUR per share paid in November 2025, the full year 2025 dividend would be 1.15 EUR per share. A timeline showing the ex-dividend, record and payment dates can be found on page 16.

 

As of 9 February 2026, we have completed approximately 635 million USD of the 6 billion USD share buyback program announced on 30 October 2025.

The 2025 Full Year Financial Report is available on our website at www.ab-inbev.com.

1The enclosed information constitutes inside information as defined in Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, and regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market. For important disclaimers and notes on the basis of preparation, please refer to page 18.

Management comments

Continued earnings growth, margin expansion and solid free cash flow generation

In 2025, we continued to execute our strategy with discipline, delivering consistent financial performance while further strengthening the fundamentals of our business. Our teams remained focused on building great brands, operating efficiently and increasing our capital allocation flexibility. Momentum improved across many of our key markets in 4Q25 and we enter 2026 well positioned to engage consumers and accelerate growth.

Beer is a vibrant and resilient category, deeply connected to consumers across social occasions and embedded in culture. While near-term demand in some key markets was impacted by a constrained consumer environment and unseasonable weather, the long-term fundamentals and growth potential of the category remain unchanged. Our brands are iconic, our geographic footprint is advantaged, and our execution capabilities continue to strengthen.

The fundamentals of our business underpinned another year of solid financial performance. Revenue increased by 2.0%, with growth in 65% of our markets. Underlying EPS increased by 6.0% in USD and 9.4% in constant currency, and we maintained our solid free cash flow generation, delivering 11.3 billion USD. Disciplined revenue management and premiumization drove a revenue per hl increase of 4.4% and efficient overhead management supported an EBITDA margin expansion of 101bps.

Our ability to deliver consistent results across varying operating conditions is a testament to the durability of our strategy and the resilience of our business.

Progressing our strategic priorities

Delivering reliable compounding growth

A central objective of our strategy is to deliver reliable compounding growth over time. While each year will have unique dynamics, our focus remains on consistent progress across the 3 pillars of our strategy to drive long-term value creation.

Since FY21, we have increased our revenue by 5 billion USD, EBITDA by 2 billion USD and free cash flow by 2 billion USD. Our Underlying EPS has increased by a CAGR of 6.7% in USD. Our financial performance has been consistent, with organic EBITDA growth within or above our medium-term growth outlook in every year. We have been disciplined in our capital allocation choices, reducing net debt by 15.3 billion USD to reach 2.87x net debt to EBITDA, progressively increased our dividend each year, including the payment of an interim dividend in 2025, completed 3.2 billion USD of share buybacks, and are currently executing a further 6 billion USD program.

The consistency of our financial performance is a reflection of our deliberate choices, clear strategic priorities and the unwavering commitment of our people to best-in-class execution.

Looking forward

We remain confident in the long-term potential of the beer category, which has structural tailwinds for growth and plays an important role in bringing people together and creating moments of celebration. The progress we have made in executing our strategy has driven consistent financial performance, increased our capital allocation flexibility and enabled increased returns to our shareholders while continuing to deleverage. We enter 2026 in a position of strength, with a highly engaged team, improved momentum across many of our key markets and with an unparalleled portfolio and lineup of mega platforms. From the Super Bowl to the Winter Olympics to the FIFA World Cup to our partnership with Netflix and, as from 2027, our sponsorship of the UEFA Men's Club Competitions, including the UEFA Champions League, we are uniquely positioned to engage consumers and activate the category. In closing, we would like to thank our colleagues around the world for their hard work, commitment, and passion, which continue to underpin our progress and performance.

2026 Outlook

(i) Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY26 reflects our current assessment of inflation and other macroeconomic conditions.

(ii) Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 190 to 220 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY26 to be approximately 4%.

(iii) Effective Tax Rate (ETR): We expect the normalized ETR in FY26 to be in the range of 26% to 28%. The ETR outlook does not consider the impact of potential future changes in legislation.

(iv) Net Capital Expenditure: We expect net capital expenditure of between 3.5 and 4.0 billion USD in FY26.

Figure 1. Consolidated performance

in USD Mio, except EPS in USD per share and Volumes in thousand hls

 

4Q24

 

4Q25

 

Organic

           

growth

Volumes

 

141 829

 

 

139 166

 

 

(1.5

)%

Beer

 

121 052

 

 

119 039

 

 

(1.9

)%

Non-Beer

 

20 777

 

 

20 127

 

 

0.6

%

Revenue

 

14 841

 

 

15 555

 

 

2.5

%

Gross profit

 

8 197

 

 

8 613

 

 

2.5

%

Gross margin

 

55.2

%

 

55.4

%

 

(1)bps

Normalized EBITDA

 

5 245

 

 

5 473

 

 

2.3

%

Normalized EBITDA margin

 

35.3

%

 

35.2

%

 

(10)bps

Normalized EBIT

 

3 824

 

 

4 049

 

 

4.5

%

Normalized EBIT margin

 

25.8

%

 

26.0

%

 

49bps

 

           

Profit attributable to equity holders of AB InBev

 

1 220

 

 

1 959

 

   

Underlying Profit

 

1 770

 

 

1 884

 

   

 

           

Basic EPS

 

0.61

 

 

0.99

 

   

Underlying EPS

 

0.88

 

 

0.95

 

 

 

   

FY24

 

FY25

 

Organic

           

growth

Volumes

 

575 706

 

 

561 100

 

 

(2.3

)%

Beer

 

496 354

 

 

484 187

 

 

(2.6

)%

Non-Beer

 

79 352

 

 

76 914

 

 

(0.4

)%

Revenue

 

59 768

 

 

59 320

 

 

2.0

%

Gross profit

 

33 024

 

 

33 179

 

 

3.4

%

Gross margin

 

55.3

%

 

55.9

%

 

78bps

Normalized EBITDA

 

20 958

 

 

21 223

 

 

4.9

%

Normalized EBITDA margin

 

35.1

%

 

35.8

%

 

101bps

Normalized EBIT

 

15 462

 

 

15 854

 

 

7.0

%

Normalized EBIT margin

 

25.9

%

 

26.7

%

 

126bps

 

           

Profit attributable to equity holders of AB InBev

 

5 855

 

 

6 837

 

   

Underlying Profit

 

7 061

 

 

7 410

 

   

 

           

Basic EPS

 

2.92

 

 

3.45

 

   

Underlying EPS

 

3.53

 

 

3.73

 

 

 

Figure 2. Volumes

in thousand hls

 

4Q24

 

Scope

 

Organic

growth

 

4Q25

 

Organic growth

                 

Total

 

Beer

North America

 

19 516

 

(216

)

 

(681

)

 

18 619

 

(3.5

)%

 

(5.5

)%

Middle Americas

 

38 907

 

(300

)

 

1 065

 

 

39 672

 

2.8

%

 

2.0

%

South America

 

44 950

 

-

 

 

(1 791

)

 

43 160

 

(4.0

)%

 

(3.7

)%

EMEA

 

24 883

 

(15

)

 

(619

)

 

24 249

 

(2.5

)%

 

(2.4

)%

Asia Pacific

 

13 439

 

1

 

 

(106

)

 

13 334

 

(0.8

)%

 

(0.8

)%

Global Export and Holding Companies

 

135

 

-

 

 

(4

)

 

131

 

(2.7

)%

 

(2.7

)%

AB InBev Worldwide

 

141 829

 

(529

)

 

(2 135

)

 

139 166

 

(1.5

)%

 

(1.9

)%

   

FY24

 

Scope

 

Organic

growth

 

FY25

 

Organic growth

                 

Total

 

Beer

North America

 

86 272

 

(961

)

 

(2 577

)

 

82 734

 

(3.0

)%

 

(3.9

)%

Middle Americas

 

150 086

 

(351

)

 

755

 

 

150 490

 

0.5

%

 

0.4

%

South America

 

160 768

 

-

 

 

(5 597

)

 

155 171

 

(3.5

)%

 

(3.8

)%

EMEA

 

93 804

 

147

 

 

(629

)

 

93 323

 

(0.7

)%

 

(0.7

)%

Asia Pacific

 

84 397

 

(91

)

 

(5 306

)

 

78 999

 

(6.3

)%

 

(6.2

)%

Global Export and Holding Companies

 

380

 

(9

)

 

13

 

 

383

 

3.4

%

 

3.4

%

AB InBev Worldwide

 

575 706

 

(1 265

)

 

(13 341

)

 

561 100

 

(2.3

)%

 

(2.6

)%

Key Markets Performance

United States: Building momentum and gaining market share in beer and spirits driven by Michelob Ultra and Cutwater

Mexico: Market share gain and margin expansion drove mid-single digit top- and bottom-line growth

Colombia: Record high volume and margin expansion drove double-digit bottom-line growth

Brazil: Improved momentum in 4Q25 with market share gain driven by our premium portfolio

Europe: Continued market share gains and premiumization partially offset a soft industry

South Africa: Continued momentum and market share gain delivered mid-single digit top- and bottom-line growth

China: Top- and bottom-line declined, impacted by volume performance

Highlights from our other markets

Consolidated Income Statement

Figure 3. Consolidated income statement

in USD Mio

 

4Q24

 

4Q25

 

Organic

           

growth

Revenue

 

14 841

 

 

15 555

 

 

2.5

%

Cost of sales

 

(6 645

)

 

(6 943

)

 

(2.6

)%

Gross profit

 

8 197

 

 

8 613

 

 

2.5

%

SG&A

 

(4 603

)

 

(4 786

)

 

(1.2

)%

Other operating income/(expenses)

 

231

 

 

223

 

 

10.5

%

Normalized EBIT

 

3 824

 

 

4 049

 

 

4.5

%

Non-underlying items above EBIT

 

269

 

 

(410

)

   

Net finance income/(expense)

 

(958

)

 

(1 070

)

   

Non-underlying net finance income/(expense)

 

(701

)

 

395

 

   

Share of results of associates

 

103

 

 

133

 

   

Non-underlying share of results of associates

 

-

 

 

-

 

   

Income tax expense

 

(848

)

 

(720

)

   

Profit

 

1 691

 

 

2 377

 

   

Profit attributable to non-controlling interest

 

471

 

 

418

 

   

Profit attributable to equity holders of AB InBev

 

1 220

 

 

1 959

 

   
             

Normalized EBITDA

 

5 245

 

 

5 473

 

 

2.3

%

Underlying Profit

 

1 770

 

 

1 884

 

 

 

   

FY24

 

FY25

 

Organic

           

growth

Revenue

 

59 768

 

 

59 320

 

 

2.0

%

Cost of sales

 

(26 744

)

 

(26 141

)

 

(0.2

)%

Gross profit

 

33 024

 

 

33 179

 

 

3.4

%

SG&A

 

(18 341

)

 

(18 133

)

 

(0.7

)%

Other operating income/(expenses)

 

779

 

 

808

 

 

10.6

%

Normalized EBIT

 

15 462

 

 

15 854

 

 

7.0

%

Non-underlying items above EBIT

 

25

 

 

(449

)

   

Net finance income/(expense)

 

(4 358

)

 

(4 280

)

   

Non-underlying net finance income/(expense)

 

(995

)

 

(185

)

   

Share of results of associates

 

329

 

 

378

 

   

Non-underlying share of results of associates

 

104

 

 

9

 

   

Income tax expense

 

(3 152

)

 

(2 850

)

   

Profit

 

7 416

 

 

8 477

 

   

Profit attributable to non-controlling interest

 

1 561

 

 

1 640

 

   

Profit attributable to equity holders of AB InBev

 

5 855

 

 

6 837

 

   
             

Normalized EBITDA

 

20 958

 

 

21 223

 

 

4.9

%

Underlying Profit

 

7 061

 

 

7 410

 

 

 

Non-underlying items above EBIT & Non-underlying share of results of associates

Figure 4. Non-underlying items above EBIT & Non-underlying share of results of associates

in USD Mio

 

4Q24

 

4Q25

 

FY24

 

FY25

Restructuring

 

(60

)

 

(48

)

 

(156

)

 

(116

)

Business and asset disposals (including impairment losses)

 

329

 

 

(322

)

 

181

 

 

(274

)

Claims and legal costs

 

-

 

 

(35

)

 

-

 

 

(53

)

Acquisition-related costs (business combinations)

 

-

 

 

(5

)

 

-

 

 

(5

)

Non-underlying items in EBIT

 

269

 

 

(410

)

 

25

 

 

(449

)

Non-underlying share of results of associates

 

-

 

 

-

 

 

104

 

 

9

 

Normalized EBIT excludes negative non-underlying items of 410 million USD in 4Q25 and 449 million USD in FY25.

Business and asset disposals (including impairment losses) for FY25 mainly comprised a loss of 214 million USD related to the planned sale of the Newark brewery and the closure of two other breweries in the United States and 60 million USD net loss related to the disposal of assets held for sale in Barbados and other Caribbean islands and the sale and impairment of non-core assets.

Non-underlying share of results from associates of FY24 included the impact from our associate Anadolu Efes’ adoption of IAS 29 hyperinflation accounting on their 2023 results.

Net finance income/(expense)

Figure 5. Net finance income/(expense)

in USD Mio

 

4Q24

 

4Q25

 

FY24

 

FY25

Net interest expense

 

(620

)

 

(607

)

 

(2 704

)

 

(2 566

)

Accretion expense and interest on pensions

 

(199

)

 

(241

)

 

(811

)

 

(821

)

Other financial results

 

(139

)

 

(221

)

 

(843

)

 

(893

)

Net finance income/(expense)

 

(958

)

 

(1 070

)

 

(4 358

)

 

(4 280

)

Non-underlying net finance income/(expense)

Figure 6. Non-underlying net finance income/(expense)

in USD Mio

 

4Q24

 

4Q25

 

FY24

 

FY25

Mark-to-market

 

(940

)

 

395

 

(1 211

)

 

(213

)

Gain/(loss) on bond redemption and other

 

239

 

 

-

 

216

 

 

28

 

Non-underlying net finance income/(expense)

 

(701

)

 

395

 

(995

)

 

(185

)

Non-underlying net finance expense in FY25 includes mark-to-market losses on derivative instruments entered into in order to hedge our share-based payment programs and shares issued in relation to the combination with Grupo Modelo and SAB.

The number of shares covered by the hedging of our share-based payment program, the deferred share instrument and the restricted shares are shown below, together with the opening and closing share prices.

Figure 7. Non-underlying equity derivative instruments

   

4Q24

 

4Q25

 

FY24

 

FY25

Share price at the start of the period (Euro)

 

59.38

 

50.80

 

58.42

 

48.25

Share price at the end of the period (Euro)

 

48.25

 

54.90

 

48.25

 

54.90

Number of equity derivative instruments at the end of the period (in million)

 

100.5

 

100.5

 

100.5

 

100.5

Income tax expense

Figure 8. Income tax expense

in USD Mio

 

4Q24

 

4Q25

 

FY24

 

FY25

Income tax expense

 

848

 

720

 

3 152

 

2 850

Effective tax rate

 

34.8%

 

24.3%

 

31.1%

 

26.1%

Normalized effective tax rate

 

26.4%

 

27.5%

 

26.5%

 

26.0%

The 4Q24, FY24 and FY25 effective tax rates were negatively impacted by non-deductible losses from derivatives related to the hedging of share-based payment programs and of the shares issued in a transaction related to the combinations with Grupo Modelo and SAB, while the 4Q25 effective tax rate was positively impacted by non-taxable gains from these derivatives.

Furthermore, the FY25 effective tax rate included 156 million USD of non-underlying tax income, while the FY24 effective tax rate included 205 million USD of non-underlying tax expense. The difference in Normalized ETR in 4Q25 and FY25 compared to 4Q24 and FY24 was primarily due to country mix.

Underlying EPS

Figure 9. Underlying EPS

in USD per share, except number of shares in million

 

4Q24

 

4Q25

 

FY24

 

FY25

Normalized EBITDA

 

2.62

 

 

2.76

 

 

10.46

 

 

10.70

 

Depreciation, amortization and impairment

 

(0.71

)

 

(0.72

)

 

(2.74

)

 

(2.71

)

Normalized EBIT

 

1.91

 

 

2.04

 

 

7.72

 

 

7.99

 

Net finance income/(expense)

 

(0.48

)

 

(0.54

)

 

(2.18

)

 

(2.16

)

Income tax expense

 

(0.38

)

 

(0.41

)

 

(1.47

)

 

(1.52

)

Associates & non-controlling interests

 

(0.18

)

 

(0.15

)

 

(0.62

)

 

(0.62

)

Hyperinflation impacts

 

0.02

 

 

0.01

 

 

0.07

 

 

0.04

 

Underlying EPS

 

0.88

 

 

0.95

 

 

3.53

 

 

3.73

 

Weighted average number of ordinary and restricted shares

 

2 003

 

 

1 984

 

 

2 003

 

 

1 984

 

Reconciliation of IFRS and Non-IFRS Financial Measures

Profit attributable to equity holders and Underlying Profit

Figure 10. Underlying Profit

in USD Mio

 

4Q24

 

4Q25

 

FY24

 

FY25

Profit attributable to equity holders of AB InBev

 

1 220

 

1 959

 

 

5 855

 

6 837

Net impact of non-underlying items on profit

 

520

 

(94

)

 

1 062

 

499

Hyperinflation impacts

 

31

 

20

 

 

145

 

74

Underlying Profit

 

1 770

 

1 884

 

 

7 061

 

7 410

Basic and Underlying EPS

Figure 11. Basic and Underlying EPS

in USD per share, except number of shares in million

 

4Q24

 

4Q25

 

FY24

 

FY25

Basic EPS

 

0.61

 

0.99

 

 

2.92

 

3.45

Net impact of non-underlying items

 

0.26

 

(0.05

)

 

0.53

 

0.25

Hyperinflation impacts

 

0.02

 

0.01

 

 

0.07

 

0.04

Underlying EPS

 

0.88

 

0.95

 

 

3.53

 

3.73

FX translation impact

 

-

 

(0.05

)

 

-

 

0.13

Underlying EPS in constant currency

 

0.88

 

0.90

 

 

3.53

 

3.86

Weighted average number of ordinary and restricted shares

 

2 003

 

1 984

 

 

2 003

 

1 984

Profit attributable to equity holders and Normalized EBITDA

Figure 12. Reconciliation of Normalized EBITDA to Profit attributable to equity holders of AB InBev

in USD Mio

 

4Q24

 

4Q25

 

FY24

 

FY25

Profit attributable to equity holders of AB InBev

 

1 220

 

 

1 959

 

 

5 855

 

 

6 837

 

Non-controlling interests

 

471

 

 

418

 

 

1 561

 

 

1 640

 

Profit

 

1 691

 

 

2 377

 

 

7 416

 

 

8 477

 

Income tax expense

 

848

 

 

720

 

 

3 152

 

 

2 850

 

Share of result of associates

 

(103

)

 

(133

)

 

(329

)

 

(378

)

Non-underlying share of results of associates

 

-

 

 

-

 

 

(104

)

 

(9

)

Net finance (income)/expense

 

958

 

 

1 070

 

 

4 358

 

 

4 280

 

Non-underlying net finance (income)/expense

 

701

 

 

(395

)

 

995

 

 

185

 

Non-underlying items above EBIT (incl. impairment losses)

 

(269

)

 

410

 

 

(25

)

 

449

 

Normalized EBIT

 

3 824

 

 

4 049

 

 

15 462

 

 

15 854

 

Depreciation, amortization and impairment

 

1 421

 

 

1 424

 

 

5 496

 

 

5 369

 

Normalized EBITDA

 

5 245

 

 

5 473

 

 

20 958

 

 

21 223

 

Normalized EBITDA, Normalized EBIT and Underlying Profit are non-IFRS financial measures used by AB InBev to reflect the company’s underlying performance. Underlying EPS and constant currency Underlying EPS are non-IFRS financial measures that AB InBev believes are useful to investors because they facilitate comparisons of EPS from period to period.

Normalized EBITDA is calculated by adjusting profit attributable to equity holders of AB InBev to exclude: (i) non-controlling interest; (ii) income tax expense; (iii) share of results of associates; (iv) non-underlying share of results of associates; (v) net finance income or cost; (vi) non-underlying net finance income or cost; (vii) non-underlying items above EBIT; and (viii) depreciation, amortization and impairment.

Underlying Profit is calculated by adjusting profit attributable to equity holders of AB InBev to exclude: (i) non-underlying items and (ii) hyperinflation impacts. Underlying EPS is calculated as Underlying Profit divided by the weighted average number of ordinary and restricted shares. Constant currency Underlying EPS is calculated as Underlying EPS excluding the effects of foreign currency translation by translating current period figures using the exchange rates from the same period in the prior year.

Normalized EBITDA, Normalized EBIT and Underlying Profit are not accounting measures under IFRS and should not be considered as an alternative to profit attributable to equity holders as a measure of operational performance, or an alternative to cash flow as a measure of liquidity. Underlying EPS and constant currency Underlying EPS are not accounting measures under IFRS and should not be considered as alternatives to earnings per share as a measure of operating performance on a per share basis. These non-IFRS financial measures do not have a standard calculation method and AB InBev’s definition of Normalized EBITDA, Normalized EBIT, Underlying Profit, Underlying EPS and constant currency Underlying EPS may not be comparable to that of other companies.

Cash Flows and Financial position

Figure 13. Cash Flow Statement (million USD)

   

FY24

 

FY25

Operating activities

       

Profit of the period

 

7 416

 

 

8 477

 

Interest, taxes and non-cash items included in profit

 

13 990

 

 

13 160

 

Cash flow from operating activities before changes in working capital and use of provisions

 

21 406

 

 

21 637

 

 

       

Change in working capital

 

(22

)

 

(398

)

Pension contributions and use of provisions

 

(374

)

 

(426

)

Interest and taxes (paid)/received

 

(6 189

)

 

(6 126

)

Dividends received

 

234

 

 

195

 

Cash flow from/(used in) operating activities

 

15 055

 

 

14 883

 

 

       

Investing activities

       

Net capex

 

(3 735

)

 

(3 552

)

Sale/(acquisition) of subsidiaries, net of cash

 

(46

)

 

18

 

Net proceeds from sale/(acquisition) of other assets

 

523

 

 

98

 

Cash flow from/(used in) investing activities

 

(3 259

)

 

(3 436

)

 

       

Financing activities

       

Net (repayments of) / proceeds from borrowings

 

(3 830

)

 

(2 460

)

Dividends paid

 

(2 672

)

 

(4 543

)

Share buyback

 

(937

)

 

(2 301

)

Payment of lease liabilities

 

(787

)

 

(733

)

Derivative financial instruments

 

(431

)

 

(206

)

Sale/(acquisition) of non-controlling interests

 

(435

)

 

(323

)

Other financing cash flows

 

(763

)

 

(883

)

Cash flow from/(used in) financing activities

 

(9 854

)

 

(11 450

)

 

       

Net increase/(decrease) in cash and cash equivalents

 

1 942

 

 

(3

)

Our free cash flow (defined as cash flow from operating activities less net capex) amounted to 11 331 million USD in FY25, in-line with FY24. Our cash and cash equivalents decreased by 3 million USD in FY25, compared to an increase of 1 942 million USD in FY24, with the following movements:

Our net debt increased to 60.9 billion USD as of 31 December 2025 from 60.6 billion USD as of 31 December 2024. Our net debt to normalized EBITDA ratio was 2.87x as of 31 December 2025. Our optimal capital structure is a net debt to normalized EBITDA ratio of around 2x.

We continue to proactively manage our debt portfolio. After bond repurchases and redemptions of 6 billion USD and issuances of 3.2 billion Euro in FY25, 98% of our bond portfolio holds a fixed-interest rate, 51% is denominated in currencies other than USD and maturities are well-distributed across the next several years.

As of 31 December 2025, we had total liquidity of 22.0 billion USD, which consisted of 11.9 billion USD of cash, cash equivalents and short-term investments in debt securities less bank overdrafts and 10.1 billion USD available under committed long-term credit facilities.

Proposed final dividend for the fiscal year 2025

The AB InBev Board of Directors proposes a final dividend of 1.00 EUR per share, subject to approval by the General Meeting of Shareholders to be held on 29 April 2026. In line with the Company’s financial discipline and deleveraging objectives, the proposed final dividend balances the Company’s capital allocation priorities and dividend policy while returning cash to shareholders. A timeline showing the ex-dividend, record and payment dates can be found below:

Dividend timeline

   

Ex-dividend date

 

Record Date

 

Payment date

Euronext

 

7 May 2026

 

8 May 2026

 

11 May 2026

MEXBOL

 

7 May 2026

 

8 May 2026

 

11 May 2026

JSE

 

6 May 2026

 

8 May 2026

 

11 May 2026

NYSE (ADR program)

 

8 May 2026

 

8 May 2026

 

5 June 2026

Restricted Shares

 

7 May 2026

 

8 May 2026

 

11 May 2026

Recent Events

Re-acquisition of minority stake in US-based Metal Container Plants

On 30 January 2026, AB InBev announced the completion of the re-acquisition of the 49.9% minority stake in AB InBev’s US-based metal container plants from a consortium of institutional investors led and/or advised by affiliates of Apollo Global Management, Inc. (NYSE: APO) for approximately 2.9 billion USD. AB InBev previously announced it had exercised its right to reacquire this minority stake in a Press Release dated January 6th.

Notes

To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. Since 1Q24, the definition of organic revenue growth has been amended to cap the price growth in Argentina to a maximum of 2% per month (26.8% year-over-year). Corresponding adjustments are made to all income statement related items in the organic growth calculations through scope changes. Scope changes also represent the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. The organic growth of our global brands, Budweiser, Stella Artois, and Corona excludes exports to Australia for which a perpetual license was granted to a third party upon disposal of the Australia operations in 2020. All references per hectoliter (per hl) exclude US non-beverage activities. Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a “normalized” basis, which means they are presented before non-underlying items. Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the Company’s performance. We are reporting the results from Argentina applying hyperinflation accounting since 3Q18. The IFRS rules (IAS 29) require us to restate the year-to-date results for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period. In FY25, we reported a negative impact from hyperinflation accounting on the profit attributable to equity holders of AB InBev of 74 million USD. The impact in FY25 Basic EPS was (0.04) USD. Values in the figures and annexes may not add up, due to rounding. 4Q25 and FY25 EPS is based upon a weighted average of 1 984 million shares compared to a weighted average of 2 003 million shares for 4Q24 and FY24.

Legal disclaimer

This release contains “forward-looking statements”. These statements are based on the current expectations and views of future events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances. The forward-looking statements contained in this release include statements other than historical facts and include statements typically containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “ambition”, “estimates”, “likely”, “foresees” and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev’s control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including, but not limited to the risks and uncertainties relating to AB InBev that are described under Item 3.D of AB InBev’s Annual Report on Form 20-F filed with the SEC on 12 March 2025. Many of these risks and uncertainties are, and will be, exacerbated by any further worsening of the global business and economic environment, including as a result of foreign currency exchange rate fluctuations and ongoing geopolitical instability. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere, including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev has made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The full year 2025 (FY25) financial data set out in Figure 1 (except for the volume information), Figures 3 to 6, 8, 10, 12 and 13 of this press release have been extracted from the group’s audited consolidated financial statements as of and for the twelve months ended 31 December 2025, which have been audited by our statutory auditors PwC Bedrijfsrevisoren BV/Réviseurs d’Entreprises SRL. The fourth quarter 2025 (4Q25) financial data set out in Figure 1 (except for the volume information), Figures 3 to 6, 8, 10 and 12, and the financial data included in Figures 7, 9, 11 and 14 of this press release have been extracted from the underlying accounting records as of and for the twelve months ended 31 December 2025. References in this document to materials on our websites, such as www.ab-inbev.com, are included as an aid to their location and are not incorporated by reference into this document.

Conference call and webcast

Investor Conference call and webcast on Thursday, 12 February 2026:
3.00pm Brussels / 2.00pm London / 9.00am New York

Registration details:
Webcast (listen-only mode):
AB InBev 4Q25 Results Webcast

To join by phone, please use one of the following two phone numbers:
Toll-Free: +1-877-407-8029
Toll: +1-201-689-8029

About AB InBev

Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Beer is the drink for moderation, and for over a century, AB InBev has championed responsible drinking. We are committed to providing our consumers with balanced choices to enjoy on any occasion. We also invest in marketing that aims to reinforce positive behaviors, and we work with communities, customers, and partners to promote responsible consumption through evidence-based initiatives.

Our diverse portfolio of well over 400 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 137 000 colleagues based in more than 40 countries worldwide. For 2025, AB InBev’s reported revenue was 59.3 billion USD (excluding JVs and associates).

Annex 1: Segment reporting (4Q)

AB InBev Worldwide

 

4Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

4Q25

 

Organic

Growth

Volumes

 

141 829

 

 

(529

)

 

-

 

 

(2 135

)

 

139 166

 

 

(1.5

)%

Revenue

 

14 841

 

 

(100

)

 

441

 

 

373

 

 

15 555

 

 

2.5

%

Cost of sales

 

(6 645

)

 

44

 

 

(173

)

 

(168

)

 

(6 943

)

 

(2.6

)%

Gross profit

 

8 197

 

 

(56

)

 

267

 

 

204

 

 

8 613

 

 

2.5

%

SG&A

 

(4 603

)

 

(7

)

 

(121

)

 

(55

)

 

(4 786

)

 

(1.2

)%

Other operating income/(expenses)

 

231

 

 

(40

)

 

12

 

 

19

 

 

223

 

 

10.5

%

Normalized EBIT

 

3 824

 

 

(103

)

 

158

 

 

169

 

 

4 049

 

 

4.5

%

Normalized EBITDA

 

5 245

 

 

(94

)

 

206

 

 

116

 

 

5 473

 

 

2.3

%

Normalized EBITDA margin

 

35.3

%

             

35.2

%

 

(10)bps

 

                       

North America

 

4Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

4Q25

 

Organic

Growth

Volumes

 

19 516

 

 

(216

)

 

-

 

 

(681

)

 

18 619

 

 

(3.5

)%

Revenue

 

3 331

 

 

(59

)

 

(6

)

 

(31

)

 

3 235

 

 

(1.0

)%

Cost of sales

 

(1 483

)

 

46

 

 

2

 

 

20

 

 

(1 416

)

 

1.4

%

Gross profit

 

1 848

 

 

(12

)

 

(4

)

 

(12

)

 

1 819

 

 

(0.6

)%

SG&A

 

(1 078

)

 

(1

)

 

2

 

 

(35

)

 

(1 112

)

 

(3.2

)%

Other operating income/(expenses)

 

8

 

 

-

 

 

0

 

 

3

 

 

12

 

 

42.4

%

Normalized EBIT

 

777

 

 

(14

)

 

(2

)

 

(43

)

 

719

 

 

(5.6

)%

Normalized EBITDA

 

969

 

 

(12

)

 

(2

)

 

(49

)

 

906

 

 

(5.1

)%

Normalized EBITDA margin

 

29.1

%

             

28.0

%

 

(122)bps

 

                       

Middle Americas

 

4Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

4Q25

 

Organic

Growth

Volumes

 

38 907

 

 

(300

)

 

-

 

 

1 065

 

 

39 672

 

 

2.8

%

Revenue

 

4 395

 

 

(34

)

 

307

 

 

259

 

 

4 927

 

 

5.9

%

Cost of sales

 

(1 601

)

 

8

 

 

(101

)

 

(63

)

 

(1 757

)

 

(4.0

)%

Gross profit

 

2 794

 

 

(26

)

 

206

 

 

195

 

 

3 170

 

 

7.0

%

SG&A

 

(975

)

 

10

 

 

(71

)

 

(10

)

 

(1 045

)

 

(1.1

)%

Other operating income/(expenses)

 

8

 

 

0

 

 

0

 

 

(3

)

 

6

 

 

(35.2

)%

Normalized EBIT

 

1 828

 

 

(15

)

 

136

 

 

182

 

 

2 130

 

 

10.0

%

Normalized EBITDA

 

2 227

 

 

(16

)

 

159

 

 

138

 

 

2 508

 

 

6.2

%

Normalized EBITDA margin

 

50.7

%

             

50.9

%

 

13bps

                         

South America

 

4Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

4Q25

 

Organic

Growth

Volumes

 

44 950

 

 

-

 

 

-

 

 

(1 791

)

 

43 160

 

 

(4.0

)%

Revenue

 

3 473

 

 

(40

)

 

36

 

 

175

 

 

3 645

 

 

5.0

%

Cost of sales

 

(1 558

)

 

24

 

 

(18

)

 

(160

)

 

(1 711

)

 

(10.3

)%

Gross profit

 

1 915

 

 

(15

)

 

19

 

 

15

 

 

1 934

 

 

0.8

%

SG&A

 

(992

)

 

(17

)

 

(18

)

 

25

 

 

(1 002

)

 

2.5

%

Other operating income/(expenses)

 

133

 

 

(42

)

 

9

 

 

25

 

 

124

 

 

31.3

%

Normalized EBIT

 

1 056

 

 

(75

)

 

10

 

 

65

 

 

1 056

 

 

6.7

%

Normalized EBITDA

 

1 310

 

 

(64

)

 

17

 

 

58

 

 

1 321

 

 

4.7

%

Normalized EBITDA margin

 

37.7

%

             

36.2

%

 

(12)bps

EMEA

 

4Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

4Q25

 

Organic

Growth

Volumes

 

24 883

 

 

(15

)

 

-

 

 

(619

)

 

24 249

 

 

(2.5

)%

Revenue

 

2 424

 

 

(29

)

 

123

 

 

6

 

 

2 524

 

 

0.2

%

Cost of sales

 

(1 276

)

 

13

 

 

(66

)

 

21

 

 

(1 308

)

 

1.6

%

Gross profit

 

1 149

 

 

(16

)

 

57

 

 

26

 

 

1 216

 

 

2.3

%

SG&A

 

(708

)

 

9

 

 

(36

)

 

(20

)

 

(755

)

 

(2.9

)%

Other operating income/(expenses)

 

51

 

 

3

 

 

3

 

 

18

 

 

75

 

 

33.0

%

Normalized EBIT

 

493

 

 

(5

)

 

24

 

 

24

 

 

536

 

 

5.0

%

Normalized EBITDA

 

776

 

 

2

 

 

40

 

 

(2

)

 

815

 

 

(0.3

)%

Normalized EBITDA margin

 

32.0

%

             

32.3

%

 

(17)bps

 

                       

Asia Pacific

 

4Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

4Q25

 

Organic

Growth

Volumes

 

13 439

 

 

1

 

 

-

 

 

(106

)

 

13 334

 

 

(0.8

)%

Revenue

 

1 122

 

 

0

 

 

(21

)

 

(48

)

 

1 053

 

 

(4.3

)%

Cost of sales

 

(589

)

 

(2

)

 

10

 

 

14

 

 

(567

)

 

2.3

%

Gross profit

 

533

 

 

(2

)

 

(11

)

 

(35

)

 

486

 

 

(6.5

)%

SG&A

 

(484

)

 

(0

)

 

9

 

 

18

 

 

(457

)

 

3.8

%

Other operating income/(expenses)

 

33

 

 

-

 

 

-

 

 

(21

)

 

13

 

 

(62.5

)%

Normalized EBIT

 

83

 

 

(2

)

 

(2

)

 

(37

)

 

42

 

 

(45.7

)%

Normalized EBITDA

 

244

 

 

1

 

 

(3

)

 

(49

)

 

192

 

 

(19.9

)%

Normalized EBITDA margin

 

21.7

%

             

18.3

%

 

(356)bps

 

                       

Global Export and Holding Companies

 

4Q24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

4Q25

 

Organic

Growth

Volumes

 

135

 

 

-

 

 

-

 

 

(4

)

 

131

 

 

(2.7

)%

Revenue

 

95

 

 

62

 

 

1

 

 

13

 

 

172

 

 

14.0

%

Cost of sales

 

(138

)

 

(46

)

 

(1

)

 

1

 

 

(183

)

 

0.9

%

Gross profit

 

(42

)

 

16

 

 

1

 

 

15

 

 

(12

)

 

34.3

%

SG&A

 

(367

)

 

(7

)

 

(8

)

 

(33

)

 

(415

)

 

(9.5

)%

Other operating income/(expenses)

 

(3

)

 

(0

)

 

(1

)

 

(4

)

 

(7

)

 

-

 

Normalized EBIT

 

(412

)

 

8

 

 

(8

)

 

(22

)

 

(434

)

 

(5.6

)%

Normalized EBITDA

 

(281

)

 

(4

)

 

(4

)

 

21

 

 

(269

)

 

7.6

%

Annex 2: Segment reporting (FY)

AB InBev Worldwide

 

FY24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

FY25

 

Organic

Growth

Volumes

 

575 706

 

 

(1 265

)

 

-

 

 

(13 341

)

 

561 100

 

 

(2.3

)%

Revenue

 

59 768

 

 

(290

)

 

(1 336

)

 

1 178

 

 

59 320

 

 

2.0

%

Cost of sales

 

(26 744

)

 

38

 

 

619

 

 

(54

)

 

(26 141

)

 

(0.2

)%

Gross profit

 

33 024

 

 

(251

)

 

(717

)

 

1 123

 

 

33 179

 

 

3.4

%

SG&A

 

(18 341

)

 

(42

)

 

383

 

 

(133

)

 

(18 133

)

 

(0.7

)%

Other operating income/(expenses)

 

779

 

 

(34

)

 

(13

)

 

77

 

 

808

 

 

10.6

%

Normalized EBIT

 

15 462

 

 

(328

)

 

(347

)

 

1 067

 

 

15 854

 

 

7.0

%

Normalized EBITDA

 

20 958

 

 

(319

)

 

(441

)

 

1 026

 

 

21 223

 

 

4.9

%

Normalized EBITDA margin

 

35.1

%

             

35.8

%

 

101bps

                         

North America

 

FY24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

FY25

 

Organic

Growth

Volumes

 

86 272

 

 

(961

)

 

-

 

 

(2 577

)

 

82 734

 

 

(3.0

)%

Revenue

 

14 655

 

 

(259

)

 

(46

)

 

(142

)

 

14 207

 

 

(1.0

)%

Cost of sales

 

(6 236

)

 

193

 

 

16

 

 

164

 

 

(5 863

)

 

2.7

%

Gross profit

 

8 419

 

 

(66

)

 

(31

)

 

21

 

 

8 345

 

 

0.3

%

SG&A

 

(4 358

)

 

(30

)

 

16

 

 

(35

)

 

(4 407

)

 

(0.8

)%

Other operating income/(expenses)

 

7

 

 

-

 

 

2

 

 

29

 

 

38

 

 

-

 

Normalized EBIT

 

4 069

 

 

(95

)

 

(13

)

 

15

 

 

3 975

 

 

0.4

%

Normalized EBITDA

 

4 791

 

 

(94

)

 

(16

)

 

6

 

 

4 687

 

 

0.1

%

Normalized EBITDA margin

 

32.7

%

             

33.0

%

 

37bps

                         

Middle Americas

 

FY24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

FY25

 

Organic

Growth

Volumes

 

150 086

 

 

(351

)

 

-

 

 

755

 

 

150 490

 

 

0.5

%

Revenue

 

17 072

 

 

(53

)

 

(451

)

 

807

 

 

17 376

 

 

4.7

%

Cost of sales

 

(6 242

)

 

(24

)

 

162

 

 

(46

)

 

(6 151

)

 

(0.7

)%

Gross profit

 

10 830

 

 

(77

)

 

(289

)

 

761

 

 

11 225

 

 

7.1

%

SG&A

 

(3 976

)

 

(0

)

 

108

 

 

(36

)

 

(3 904

)

 

(0.9

)%

Other operating income/(expenses)

 

34

 

 

0

 

 

(1

)

 

(13

)

 

21

 

 

(36.4

)%

Normalized EBIT

 

6 889

 

 

(77

)

 

(182

)

 

712

 

 

7 342

 

 

10.4

%

Normalized EBITDA

 

8 400

 

 

(79

)

 

(224

)

 

588

 

 

8 685

 

 

7.0

%

Normalized EBITDA margin

 

49.2

%

             

50.0

%

 

108bps

                         

South America

 

FY24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

FY25

 

Organic

Growth

Volumes

 

160 768

 

 

-

 

 

-

 

 

(5 597

)

 

155 171

 

 

(3.5

)%

Revenue

 

12 423

 

 

(80

)

 

(999

)

 

610

 

 

11 954

 

 

4.9

%

Cost of sales

 

(6 073

)

 

(46

)

 

531

 

 

(300

)

 

(5 888

)

 

(4.9

)%

Gross profit

 

6 350

 

 

(126

)

 

(468

)

 

310

 

 

6 066

 

 

4.9

%

SG&A

 

(3 779

)

 

(33

)

 

317

 

 

(60

)

 

(3 555

)

 

(1.6

)%

Other operating income/(expenses)

 

452

 

 

(51

)

 

(19

)

 

44

 

 

426

 

 

11.6

%

Normalized EBIT

 

3 024

 

 

(210

)

 

(170

)

 

294

 

 

2 937

 

 

10.2

%

Normalized EBITDA

 

4 052

 

 

(195

)

 

(251

)

 

294

 

 

3 901

 

 

7.5

%

Normalized EBITDA margin

 

32.6

%

             

32.6

%

 

78bps

EMEA

 

FY24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

FY25

 

Organic

Growth

Volumes

 

93 804

 

 

147

 

 

-

 

 

(629

)

 

93 323

 

 

(0.7

)%

Revenue

 

9 003

 

 

(36

)

 

250

 

 

284

 

 

9 502

 

 

3.2

%

Cost of sales

 

(4 678

)

 

31

 

 

(128

)

 

(56

)

 

(4 832

)

 

(1.2

)%

Gross profit

 

4 325

 

 

(4

)

 

122

 

 

228

 

 

4 670

 

 

5.3

%

SG&A

 

(2 701

)

 

(45

)

 

(80

)

 

(60

)

 

(2 886

)

 

(2.2

)%

Other operating income/(expenses)

 

177

 

 

17

 

 

7

 

 

33

 

 

234

 

 

17.2

%

Normalized EBIT

 

1 801

 

 

(32

)

 

49

 

 

201

 

 

2 019

 

 

11.4

%

Normalized EBITDA

 

2 847

 

 

(26

)

 

80

 

 

198

 

 

3 098

 

 

7.0

%

Normalized EBITDA margin

 

31.6

%

             

32.6

%

 

117bps

                         

Asia Pacific

 

FY24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

FY25

 

Organic

Growth

Volumes

 

84 397

 

 

(91

)

 

-

 

 

(5 306

)

 

78 999

 

 

(6.3

)%

Revenue

 

6 196

 

 

(6

)

 

(92

)

 

(404

)

 

5 693

 

 

(6.5

)%

Cost of sales

 

(2 970

)

 

(19

)

 

42

 

 

205

 

 

(2 741

)

 

6.9

%

Gross profit

 

3 227

 

 

(25

)

 

(50

)

 

(199

)

 

2 952

 

 

(6.2

)%

SG&A

 

(2 059

)

 

(13

)

 

32

 

 

96

 

 

(1 944

)

 

4.6

%

Other operating income/(expenses)

 

116

 

 

0

 

 

0

 

 

(30

)

 

86

 

 

(26.2

)%

Normalized EBIT

 

1 284

 

 

(38

)

 

(18

)

 

(134

)

 

1 094

 

 

(10.6

)%

Normalized EBITDA

 

1 933

 

 

(35

)

 

(25

)

 

(172

)

 

1 700

 

 

(9.0

)%

Normalized EBITDA margin

 

31.2

%

             

29.9

%

 

(81)bps

                         

Global Export and Holding Companies

 

FY24

 

Scope

 

Currency

Translation

 

Organic

Growth

 

FY25

 

Organic

Growth

Volumes

 

380

 

 

(9

)

 

-

 

 

13

 

 

383

 

 

3.4

%

Revenue

 

418

 

 

144

 

 

3

 

 

23

 

 

588

 

 

6.1

%

Cost of sales

 

(546

)

 

(98

)

 

(3

)

 

(21

)

 

(667

)

 

(4.1

)%

Gross profit

 

(128

)

 

46

 

 

0

 

 

2

 

 

(79

)

 

1.8

%

SG&A

 

(1 468

)

 

79

 

 

(11

)

 

(38

)

 

(1 438

)

 

(2.8

)%

Other operating income/(expenses)

 

(8

)

 

-

 

 

(2

)

 

14

 

 

3

 

 

-

 

Normalized EBIT

 

(1 604

)

 

125

 

 

(14

)

 

(22

)

 

(1 513

)

 

(1.5

)%

Normalized EBITDA

 

(1 065

)

 

110

 

 

(5

)

 

111

 

 

(848

)

 

11.6

%

Annex 3: Consolidated statement of financial position (FY)

Million US dollar

 

31 December 2024

 

31 December 2025

         

ASSETS

       

Non-current assets

       

Property, plant and equipment

 

23 503

 

23 664

Goodwill

 

110 479

 

117 908

Intangible assets

 

40 034

 

41 985

Investments in associates

 

4 612

 

5 002

Investment securities

 

168

 

161

Deferred tax assets

 

2 493

 

2 708

Pensions and similar obligations

 

42

 

150

Income tax receivables

 

470

 

444

Derivatives

 

261

 

145

Trade and other receivables

 

1 577

 

1 871

Total non-current assets

 

183 637

 

194 039

         

Current assets

       

Investment securities

 

221

 

306

Inventories

 

5 020

 

5 107

Income tax receivables

 

727

 

785

Derivatives

 

554

 

583

Trade and other receivables

 

5 270

 

6 161

Cash and cash equivalents

 

11 174

 

11 638

Assets classified as held for sale

 

33

 

190

Total current assets

 

22 999

 

24 769

         

Total assets

 

206 637

 

218 808

         

EQUITY AND LIABILITIES

       

Equity

       

Issued capital

 

1 736

 

1 736

Share premium

 

17 620

 

17 620

Reserves

 

12 304

 

17 803

Retained earnings

 

46 577

 

50 128

Equity attributable to equity holders of AB InBev

 

78 237

 

87 287

         

Non-controlling interests

 

10 463

 

10 449

Total equity

 

88 700

 

97 736

         

Non-current liabilities

       

Interest-bearing loans and borrowings

 

70 720

 

72 128

Pensions and similar obligations

 

1 296

 

1 275

Deferred tax liabilities

 

11 321

 

11 400

Income tax payables

 

284

 

206

Derivatives

 

68

 

293

Trade and other payables

 

797

 

869

Provisions

 

385

 

425

Total non-current liabilities

 

84 871

 

86 596

         

Current liabilities

       

Bank overdrafts

 

-

 

14

Interest-bearing loans and borrowings

 

1 449

 

885

Income tax payables

 

1 805

 

1 825

Derivatives

 

5 817

 

6 104

Trade and other payables

 

23 804

 

25 455

Provisions

 

191

 

192

Total current liabilities

 

33 066

 

34 475

         

Total equity and liabilities

 

206 637

 

218 808

Annex 4: Consolidated statement of cash flows (FY)

For the year ended 31 December

       

Million US dollar

 

2024

 

2025

         

OPERATING ACTIVITIES

       

Profit of the period

 

7 416

 

 

8 477

 

Depreciation, amortization and impairment

 

5 544

 

 

5 652

 

Net finance expense/(income)

 

5 353

 

 

4 465

 

Equity-settled share-based payment expense

 

644

 

 

625

 

Income tax expense

 

3 152

 

 

2 850

 

Share of results of associates

 

(433

)

 

(387

)

Other non-cash items

 

(269

)

 

(45

)

Cash flow from operating activities before changes in working capital and use of provisions

 

21 406

 

 

21 637

 

Decrease/(increase) in trade and other receivables

 

341

 

 

(187

)

Decrease/(increase) in inventories

 

(149

)

 

87

 

Increase/(decrease) in trade and other payables

 

(215

)

 

(298

)

Pension contributions and use of provisions

 

(374

)

 

(426

)

Cash generated from operations

 

21 009

 

 

20 814

 

Interest paid

 

(3 649

)

 

(3 348

)

Interest received

 

594

 

 

462

 

Dividends received

 

234

 

 

195

 

Income tax paid

 

(3 134

)

 

(3 240

)

Cash flow from/(used in) operating activities

 

15 055

 

 

14 883

 

         

INVESTING ACTIVITIES

       

Acquisition of property, plant and equipment and of intangible assets

 

(3 863

)

 

(3 656

)

Proceeds from sale of property, plant and equipment and of intangible assets

 

128

 

 

104

 

Sale/(acquisition) of subsidiaries, net of cash

 

(46

)

 

18

 

Proceeds from sale/(acquisition) of other assets

 

523

 

 

98

 

Cash flow from/(used in) investing activities

 

(3 259

)

 

(3 436

)

         

FINANCING ACTIVITIES

       

Proceeds from borrowings

 

5 465

 

 

4 400

 

Repayments of borrowings

 

(9 295

)

 

(6 861

)

Dividends paid

 

(2 672

)

 

(4 543

)

Share buyback

 

(937

)

 

(2 301

)

Payment of lease liabilities

 

(787

)

 

(733

)

Derivative financial instruments

 

(431

)

 

(206

)

Sale/(acquisition) of non-controlling interests

 

(435

)

 

(323

)

Other financing cash flows

 

(763

)

 

(883

)

Cash flow from/(used in) financing activities

 

(9 854

)

 

(11 450

)

         

Net increase/(decrease) in cash and cash equivalents

 

1 942

 

 

(3

)

Cash and cash equivalents less bank overdrafts at beginning of year

 

10 314

 

 

11 174

 

Effect of exchange rate fluctuations

 

(1 082

)

 

452

 

Cash and cash equivalents less bank overdrafts at end of period

 

11 174

 

 

11 623

 

 

 

Contacts

Investors
Shaun Fullalove
E-mail: shaun.fullalove@ab-inbev.com

Ekaterina Baillie
E-mail: ekaterina.baillie@ab-inbev.com

Patrick Ryan
E-mail: patrick.ryan@ab-inbev.com

Media
Media Relations
E-mail: media.relations@ab-inbev.com

Figure 14. Terms and debt repayment schedule as of 31 December 2025 (billion USD)

反对 0
举报 0
收藏 0
打赏 0
评论 0
Echodyne被指定为Trust Automation价值4.9亿美元美国空军反无人机系统工程合同的雷达系统供应商
EchoShield雷达集成至小型无人机防空系统(SUADS),助力履行4.9亿美元空军不定期交付/不确定数量(IDIQ)合同 华盛顿州柯克兰--(美国商业资讯)--雷达平台公司Echodyne今日宣布,其产品被选为Trust Automation小型无人机防空系统(SUADS)反无人机系统平台的主力雷达系统,该系统将依据2025年8月公布的4.9亿美元IDIQ合同交付给美国空军。 可快速部署型小型无人机防空系统(RD-SUADS)、固定站点型小型无人机防空系统(FS-SUADS)和远征型...

0评论2026-04-222035

迪拜本土独角兽企业领导人盛赞迪拜是塑造未来科技、推动数字经济发展的全球创新中心
阿联酋迪拜--(美国商业资讯)--多家总部位于迪拜的独角兽企业的领导人重申,迪拜酋长国是全球数字创新和科技驱动型增长的中心。这些高管强调,迪拜具有前瞻性的监管环境、先进的基础设施和吸引国际人才的能力,这些也是其对高增长数字企业的吸引力持续提升的关键因素。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20260420479234/zh-CN/ 他们指出,迪拜已成长为雄心勃勃的企业的战略跳板,其灵活的商业环境支持...

0评论2026-04-221110

Horse Powertrain推出X-Range C15直驱动力总成,助力纯电车平台的混动化改造
北京--(美国商业资讯)--全球领先的创新低排放动力总成系统制造商Horse Powertrain将在2026年北京车展上发布全新“一体化”动力总成:X-Range C15直驱系统。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20260419829454/zh-CN/ 这款超紧凑型X-Range C15直驱系统将全混合动力总成集成于一个共用壳体的紧凑单元中,设计安装于后副车架,通过双...

0评论2026-04-221843

有關向MIZUHO FINANCIAL GROUP, INC.( 東京: 8411)及ORIENT CORPORATION( 東京: 8585)提出股東提案,以及啟動活動網站之事宜
東京--(美國商業資訊)-- Strategic Capital, Inc.: 敬啟者: Strategic Capital, Inc.(下稱「Strategic Capital」)與INTERTRUST TRUSTEES (CAYMAN) LIMITED(僅以JAPAN-UP受託人身分行事,下稱「該基金」)簽署全權委託投資合約。該基金與Strategic Capital(下稱「我們」)在過去六個月或更長時間內,持續持有Mizuho Financial Group, Inc.(下稱「...

0评论2026-04-221170

清洁设计:SaniSure推出PETG PharmaTainer超洁净试剂瓶和发酵瓶
行业应用最广泛的PETG材料达到行业领先的洁净度、合规性和无RNase/DNase验证标准,现已覆盖完整生物工艺工作流程。 加州卡马里奥--(美国商业资讯)-- SaniSure®今日宣布推出PETG PharmaTainer™全新系列生物工艺用试剂瓶和发酵瓶,这些产品将广受认可的医用级Eastman Eastar® PETG 6763树脂(DMF备案号:9987)与SaniSure的专有工艺和先进自动化技术相结合。本次发布拓展了SaniSure成熟的PharmaT...

0评论2026-04-221687

Inspirit Capital将收购Kaplan Languages Group
伦敦--(美国商业资讯)--专注于企业分拆业务投资的Inspirit Capital欣然宣布,计划从Kaplan手中收购全球领先的语言教育平台KLG Kaplan Languages Group (“KLG”)。本次出售的所有条件均已达成,预计交易将于5月1日完成。 KLG旗下拥有Kaplan International Languages、Alpadia Language Schools、Azurlingua和ESL Education。自2006年以来,KLG...

0评论2026-04-221640

Wolters Kluwer Future Ready CFO report shows APAC CFOs embrace AI with a governancefirst mindset, closely aligned with global peers
Finance leaders across AsiaPacific recognize AI as a major force reshaping finance, while advancing adoption with disciplined focus on governance, value, and oversight SINGAPORE--(BUSINESS WIRE)--CFOs across AsiaPacific are accelerating ...

0评论2026-04-221597

Chemelex对Algo8进行少数股权投资,以推动AI驱动的制造业发展
休斯顿--(美国商业资讯)--电热和传感解决方案领域的全球领导者Chemelex今日宣布,已对工业人工智能(AI)公司Algo8进行少数股权投资,以加速AI在制造业中的应用。 本次投资将支持Algo8进一步开展技术研发,同时使Chemelex能够强化其制造流程、提升生产效率,并持续向客户交付高品质产品。 Chemelex首席执行官David Prystash将加入Algo8的顾问委员会。 此次合作建立在现有商业合作基础之上,也体现了Chemelex致力于运用先进技术,提升其全球制...

0评论2026-04-221416

轻松入夏* *叠穿随心 一眼盟可睐
由Jamie Dornan出镜演绎的全球广告大片,主题“轻松入夏”(Puffy Summer)所呈现的不只是季节的更替,它代表着盟可睐Moncler品牌基因在更轻盈、更明亮的户外时光中的延伸与进化。 米兰--(美国商业资讯)--进入悠闲松弛的夏日季,Moncler Collection 为更轻盈、更明媚的户外时光重新构想品牌标志性的蓬松质感。全新概念体现在一系列应对换季天气的服饰中:质感柔和、廓形立体、色彩缤纷,恰到好处的蓬松感塑就叠穿风格——由Jamie Dornan...

0评论2026-04-221941

Perma-Pipe International Holdings, Inc.公布创纪录的2025财年第四季度及全年业绩:净销售额增长33%,净利润增长89%
本季度净销售额增至5,510万美元,全年达2.109亿美元,上年同期分别为4,500万美元和1.584亿美元 本季度所得税前利润提升至640万美元,全年达2,750万美元,上年同期分别为530万美元和1,850万美元 按照美国通用会计准则(GAAP)计算的摊薄每股收益,本季度为0.60美元,全年为2.09美元,上年同期分别为0.22美元和1.12美元 期末在手订单达1.216亿美元,反映出本季度订单向收入转化的强劲势头 美国德克萨斯州伍德兰兹--(美国商业资讯)-- Perma-...

0评论2026-04-221317